Outcome of SARS-CoV-2 infection linked to MAIT cell activation and cytotoxicity: evidence for an IL-18 dependent mechanism
H. Flament, M. Rouland, L. Beaudoin, A. Toubal, L. Bertrand, S. Lebourgeois, Z. Gouda, C. Rousseau, P. Soulard, M. Hurtado-Nedelec, S. Luce, K. Bailly, M. Andrieu, C. Boitard, A. Vallet-Pichard, JF. Gautier, N. Ajzenberg, B. Terrier, F. Pene, J. Ghosn, Y. Yazdanpanah, B. Visseaux, D. Descamps, JF. Timsit, R.C. Monteiro, View ORCID ProfileA. Lehuen
doi: https://doi.org/10.1101/2020.08.31.20185082
H. Flament
1Immunological Dysfunction Unit, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; University of Paris, Center for Research on Inflammation (CRI), Inserm U1149 & CNRS ERL8252, Inflamex Laboratory, Paris, France
M. Rouland
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
L. Beaudoin
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
A. Toubal
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
L. Bertrand
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
S. Lebourgeois
3Department of Virology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; Infections Antimicrobials Modelling Evolution (IAME) UMR 1137, University of Paris, Paris, France
Z. Gouda
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
C. Rousseau
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
P. Soulard
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
M. Hurtado-Nedelec
1Immunological Dysfunction Unit, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; University of Paris, Center for Research on Inflammation (CRI), Inserm U1149 & CNRS ERL8252, Inflamex Laboratory, Paris, France
S. Luce
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
K. Bailly
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
M. Andrieu
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
C. Boitard
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
4Department of Diabetology, Assistance Publique-Hôpitaux de Paris, Cochin University Hospital, Paris, France
A. Vallet-Pichard
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
5Department of Hepatology, Assistance Publique-Hôpitaux de Paris, Cochin University Hospital, Paris, France
JF. Gautier
6Department of Diabetes and Endocrinology, Lariboisière Hospital, AP-HP, Paris, France
N. Ajzenberg
7Department of Hematology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; University of Paris, LVTS, INSERM 1148, Paris, France
B. Terrier
8Medical Intensive Care Unit, Assistance Publique-Hôpitaux de Paris Cochin University Hospital, Paris, France
F. Pene
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
9Department of Internal Medicine, Assistance Publique-Hôpitaux de Paris, Cochin University Hospital, Paris, France
J. Ghosn
10Department of Infectious and Tropical Diseases, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; Infections Antimicrobials Modelling Evolution (IAME) UMR 1137, University of Paris, Paris, France
Y. Yazdanpanah
10Department of Infectious and Tropical Diseases, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; Infections Antimicrobials Modelling Evolution (IAME) UMR 1137, University of Paris, Paris, France
B. Visseaux
3Department of Virology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; Infections Antimicrobials Modelling Evolution (IAME) UMR 1137, University of Paris, Paris, France
D. Descamps
3Department of Virology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; Infections Antimicrobials Modelling Evolution (IAME) UMR 1137, University of Paris, Paris, France
JF. Timsit
11Medical and Infectious Diseases Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; Infections Antimicrobials Modelling Evolution (IAME) UMR 1137, University of Paris, Paris, France
R.C. Monteiro
1Immunological Dysfunction Unit, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; University of Paris, Center for Research on Inflammation (CRI), Inserm U1149 & CNRS ERL8252, Inflamex Laboratory, Paris, France
A. Lehuen
2University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France
Posted September 02, 2020.
Outcome of SARS-CoV-2 infection linked to MAIT cell activation and cytotoxicity: evidence for an IL-18 dependent mechanism
H. Flament, M. Rouland, L. Beaudoin, A. Toubal, L. Bertrand, S. Lebourgeois, Z. Gouda, C. Rousseau, P. Soulard, M. Hurtado-Nedelec, S. Luce, K. Bailly, M. Andrieu, C. Boitard, A. Vallet-Pichard, JF. Gautier, N. Ajzenberg, B. Terrier, F. Pene, J. Ghosn, Y. Yazdanpanah, B. Visseaux, D. Descamps, JF. Timsit, R.C. Monteiro, A. Lehuen
medRxiv 2020.08.31.20185082; doi: https://doi.org/10.1101/2020.08.31.20185082
Outcome of SARS-CoV-2 infection linked to MAIT cell activation and cytotoxicity: evidence for an IL-18 dependent mechanism
H. Flament, M. Rouland, L. Beaudoin, A. Toubal, L. Bertrand, S. Lebourgeois, Z. Gouda, C. Rousseau, P. Soulard, M. Hurtado-Nedelec, S. Luce, K. Bailly, M. Andrieu, C. Boitard, A. Vallet-Pichard, JF. Gautier, N. Ajzenberg, B. Terrier, F. Pene, J. Ghosn, Y. Yazdanpanah, B. Visseaux, D. Descamps, JF. Timsit, R.C. Monteiro, A. Lehuen
medRxiv 2020.08.31.20185082; doi: https://doi.org/10.1101/2020.08.31.20185082
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2931)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12734)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4578)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (424)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4345)
- Nursing (236)
- Nutrition (638)
- Oncology (2266)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1526)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)